HCV: Hepatitis C Virus; GT: Genotype; IL28B: Interleukin 28B (genetic variant associated with HCV treatment response); pegIFN: Pegylated Interferon; RBV: Ribavirin; eRVR: Extended Rapid Virologic Response; SVR12: Sustained Virologic Response 12 weeks post-treatment; DAAs: Direct-Acting Antivirals; EBR/GZR: Elbasvir/Grazoprevir; SOF/PR: Sofosbuvir/Peginterferon and Ribavirin; OBV/PTV/r: Ombitasvir/Paritaprevir/Ritonavir; DSV: Dasabuvir; METAVIR: Scoring system for liver fibrosis and cirrhosis; SVR24: Sustained Virologic Response 24 weeks post-treatment. This evidence concerns the gene IFNL3 and Cirrhosis.